Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07478497 · ClinicalTrials.gov registry record · NA
30 Day Insulin Balance Metabolic Health Optimization Protocol
A NA study of Insulin, sponsored by Efforia.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07478497: Recruiting NA study of Insulin, sponsored by Efforia.
NCT07478497 is a NA study of Insulin that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, above the 65-participant average among 6 other Insulin trials with a reported enrollment target (54% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07478497, a NA study of Insulin, is actively recruiting participants, sponsored by Efforia.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Explore how a dietary supplement can help support healthy insulin levels and its impact on weight, fatigue, and sugar cravings. The Insulin Balance Formula and Hormetics Weight Optimization System is designed for people who are generally healthy and want to support and maintain healthy insulin levels to reach general health goals.
Primary Outcome
Waist circumference will be measured in centimeters (cm) using a non-elastic, flexible anthropometric tape measure. Measurements will be taken at the midpoint between the lowest rib and the iliac crest with the participant standing, at the end of a normal exhalation. Two measurements will be obtained, and the average value will be recorded.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Insulin Balance Formula - Hormetics Weight Optimization System
Study Locations (1)
New York
- Efforia - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-10-21 |
| Est. Completion | 2026-10-21 |
| Phase | NA |
What NCT07478497 shows while recruiting
NCT07478497 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 65-participant average among 6 other Insulin trials with a reported enrollment target (54% higher).
The record links to 1 condition, with Insulin appearing as the primary indexed condition, and to 1 intervention - of which Insulin Balance Formula - Hormetics Weight Optimization System is the first listed.
NCT07478497 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07478497 about?
NCT07478497 is a clinical study titled "30 Day Insulin Balance Metabolic Health Optimization Protocol". Explore how a dietary supplement can help support healthy insulin levels and its impact on weight, fatigue, and sugar cravings. The Insulin Balance Formula and Hormetics Weight Optimization System is designed for people who are generally healthy and want to support and maintain healthy insulin level...
What is the current status of trial NCT07478497?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-21. Estimated completion is 2026-10-21.
What conditions does trial NCT07478497 study?
This clinical trial studies the following conditions: Insulin.
What interventions are being tested in trial NCT07478497?
The interventions under investigation include: Insulin Balance Formula - Hormetics Weight Optimization System (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07478497?
This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07478497 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes
RECRUITING · NA
-
Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
RECRUITING · Phase 2
-
Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
COMPLETED
-
Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
COMPLETED · Phase 2
-
Effect of High-Legume Diet on Colorectal Cancer Risk
COMPLETED · Early Phase 1
-
Effect of Diet on Vascular Disease in Pre-Menopausal Women
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI